Major Trials Begin on 'HIV Pill'

PreP, a new drug which temporarily boosts immunity to people who've been exposed to the HIV retrovirus is beginning a massive human clinical trial on three separate continents, but also causing medical professionals to question whether such a pill could actually cause more HIV infections if found effective. Doctors are concerned that users of the pill may stop using condoms and other protective measures if the pill was made available on a mass scale.